NovaBay Pharma (NBY) Misses Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Other income (expense), net: -52K
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Other income (expense), net: -52K
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.26), $0.14 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.69 million versus the consensus estimate of $3.89 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
- SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
